首页> 外文OA文献 >An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas

【2h】

An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas

机译：开放标签，单臂，两级，多中心，期II研究，以评估TLC388和基因组分析对差异差异化神经内分泌癌的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ming‐Huang Chen; Wen‐Chi Chou; Chin‐Fu Hsiao; Shih Sheng Jiang; Hui‐Jen Tsai; Yi‐Chang Liu; Chiun Hsu; Yan‐Shen Shan; Yi‐Ping Hung; Chia‐Hsun Hsich; Chao‐Hua Chiu; Ta‐Chih Liu; Shih‐Feng Cho; Tsang‐Wu Liu; Yee Chao;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas [J] . Chen Ming‐Huang, Chou Wen‐Chi, Hsiao Chin‐Fu, The oncologist . 2020,第5期

机译：开放标签，单臂，两级，多中心，期II研究，以评估TLC388和基因组分析对差异差异化神经内分泌癌的疗效
2. An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas [J] . Ming-Huang Chen, Chia-Hsun Hsich, Chao-Hua Chiu, The oncologist . 2020,第5期

机译：开放标签，单臂，两级，多中心，期II研究，以评估TLC388和基因组分析对差异差异化神经内分泌癌的疗效
3. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial [J] . Luca Filippi, Giacomo Cavallaro, Elettra Berti, BMC Pediatrics . 2017,第1期

机译：研究方案：早熟性视网膜病变早熟的新生儿中普萘洛尔0.2％滴眼液的安全性和有效性（DROP-ROP-0.2％）：一项多中心，开放标签，单臂，II期试验
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. An Open‐Label Single‐Arm Two‐Stage Multicenter Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas [O] . Ming‐Huang Chen, Wen‐Chi Chou, Chin‐Fu Hsiao, 2020

机译：一项开放标签单臂两阶段多中心II期研究用于评估TLC388的疗效和基因组分析对分化较差的神经内分泌癌的疗效
7. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial [O] . Filippi, L, Cavallaro, G, Berti, E, 2017

机译：研究方案：早熟性视网膜病变早熟的新生儿中普萘洛尔0.2％滴眼液的安全性和有效性（DROP-ROP-0.2％）：一项多中心，开放标签，单臂，II期试验

An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas

著录项

引文网络

相似文献

相关主题

期刊订阅